PNC Financial Services Group
CRDF icon

PNC Financial Services Group’s Cardiff Oncology CRDF Stock Holding History

PNC Financial Services Group’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.15K Buy
707
+649
+1,119% +$1.33K ﹤0.01% 4725
2025
Q4 		$163 Sell
58
-178
-75% -$413 ﹤0.01% 5002
2025
Q3 		$486 Buy
+236
New +$652 ﹤0.01% 4807
2025
Q1 		– Sell
-1,520
Closed -$6.6K – 4922
2024
Q4 		$6.6K Hold
1,520
– – ﹤0.01% 3949
2024
Q3 		$4.06K Hold
1,520
– – ﹤0.01% 4099
2024
Q2 		$3.37K Hold
1,520
– – ﹤0.01% 4111
2024
Q1 		$8.12K Hold
1,520
– – ﹤0.01% 3817
2023
Q4 		$2.25K Hold
1,520
– – ﹤0.01% 4172
2023
Q3 		$2.11K Hold
1,520
– – ﹤0.01% 4226
2023
Q2 		$2.23K Hold
1,520
– – ﹤0.01% 4350
2023
Q1 		$2.51K Buy
1,520
+520
+52% +$893 ﹤0.01% 4251
2022
Q4 		$1.4K Buy
+1,000
New +$1.43K ﹤0.01% 4339
2022
Q1 		– Sell
-3,000
Closed -$18K – 4550
2021
Q4 		$18K Buy
+3,000
New +$17.9K ﹤0.01% 3586
2019
Q4 		– Sell
-1,000
Closed -$2K – 4003
2019
Q3 		$2K Buy
+1,000
New +$1.95K ﹤0.01% 3845
2017
Q1 		– Sell
-14
Closed -$2K – 4119
2016
Q4 		$2K Buy
+14
New +$3.27K ﹤0.01% 3826

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

PNC Financial Services Group's CRDF Position: Q1 2026 in Review

PNC Financial Services Group increased its Cardiff Oncology (CRDF) stake by 1,119% in Q1 2026, buying an estimated $1.33K and bringing the position to 707 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #4725.

PNC Financial Services Group first reported a position in CRDF in Q4 2016 and has held it in 15 quarters since. The position peaked at $18K in Q4 2021. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • PNC Financial Services Group held 707 shares of Cardiff Oncology worth $1.15K as of Q1 2026.
  • PNC Financial Services Group bought 649 Cardiff Oncology shares in Q1 2026, an estimated $1.33K.
  • Cardiff Oncology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4725 holding.
  • PNC Financial Services Group first reported a position in Cardiff Oncology in Q4 2016 and has held it in 15 quarters since.
  • PNC Financial Services Group's Cardiff Oncology position peaked at $18K in Q4 2021.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.